Product Images Propafenone Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Propafenone Hydrochloride NDC 0591-2286 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image 1
image 2
The given text seems to be a chart showing the Proportion of Patients Without Event at different time intervals. Two drugs are being compared- Propafenone R and Placcbo. Propafenone R shows more patients without an event as compared to Placcbo. There is also a mention of three different drugs and their dosages- Propafenone ER 235 mg bid, Propafenone ER 326 mg bid, and Propafenone ER 425 mg bid. It also mentions a patient who was followed for 300 days but had an event on day 291, leading to a decline in the Kaplan-Meier curves.*
image 3
This seems to be a label of a medication named "Proafenone Hydrochloride" in extended-release capsule form, containing 225mg. It is meant for oral consumption only and to be taken under prescription only. The rest of the text seems to be either unreadable or irrelevant.*
image 4
This is a description of a medicine called Propafenone Hydrochloride which is available in extended-release capsules form with a pack containing 60 capsules. The recommended dosage is available on the package insert. The text also includes a product code: NDCoSON-2286.60 and a code: 2202271 on Vanish/Coding Area.*
image 5
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.